Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis

doi:10.4254/wjh.v16.i7.995

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1599)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

HTML

809

Figures (1-2)

115

Tables (1-5)

Sum=1032

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

180

Download

218

Sum=398

Publishing Process of This Article

Item

Count

Browse

Download

Sum=126

Jul 27, 2024 (publication date) through Oct 5, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Jul 27, 2024; 16(7): 995-1008
Published online Jul 27, 2024. doi: 10.4254/wjh.v16.i7.995

Table 1 Follow up schedule of enrolled chronic hepatitis B patients, Harar, Eastern Ethiopia

Laboratory test	On treatment	Not on treatment
After 4 weeks	CBC, ALT, AST, creatinine
Every 3 months	CBC, ALT, AST, creatinine HIV rapid test	CBC, ALT, AST, creatinine
Every 6 months	HBsAg, HBV DNA viral load, HBeAg/anti-HBe (only if HBeAg-positive previously)	HBsAg, HBV DNA viral load
Every 12 months	Abdominal ultrasound as screening for HCC

ALT: Alanine aminotransferase; anti-HBe: Hepatitis B envelope antigen antibody; AST: Aspartate aminotransferase; CBC: Complete blood count; HBeAg: Hepatitis B envelope antigen; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma.

Table 2 Baseline characteristics of patients with chronic hepatitis B, by cirrhosis status, Harar, Eastern Ethiopia

Variable	All patients, n = 193	No cirrhosis, n = 133	Cirrhosis, n = 60	P value
Sex, n (%)				0.020^a
Male	132 (68.4)	84 (63.2)	48 (80.0)
Female	61 (31.6)	49 (36.8)	12 (20.0)
Age group by years, n (%)				0.852
18-25	69 (35.8)	47 (35.3)	22 (36.7)
26-35	70 (36.3)	47 (35.3)	23 (38.3)
36-45	36 (18.7)	18 (13.5)	18 (30.0)
> 45	18 (9.3)	14 (10.5)	4 (6.7)
Marital status¹, n (%)				0.597
Single	61 (31.6)	45 (33.8)	16 (26.6)
Married	123 (63.7)	81 (60.9)	42 (70.0)
Divorced/widowed	3 (1.6)	2 (1.5)	1 (1.7)
Address, n (%)				0.032^a
Harar	48 (24.9)	40 (30.0)	8 (13.3)
Dire Dawa	56 (29.0)	42 (31.6)	14 (23.3)
Oromia	71 (36.8)	34 (25.6)	37 (61.7)
Somali	18 (9.3)	17 (12.8)	1 (1.7)
Occupation², n (%)				0.009^a
Farmer	33 (17.1)	14 (10.5)	19 (31.7)
Housewife	29 (15.0)	22 (16.5)	7 (11.7)
Student	23 (11.9)	14 (10.5)	9 (15.0)
Public servant	31 (16.1)	26 (19.5)	5 (8.3)
Self employed	18 (9.3)	12 (9.0)	6 (10.0)
Others	19 (9.8)	14 (10.5)	5 (8.3)
Family history of liver cancer³, n (%)				0.569
No	183 (94.8)	125 (93.9)	58 (96.7)
Yes	9 (4.7)	7 (5.3)	2 (3.3)
Traditional herbal medicine⁴, n (%)				0.220
No	169 (87.6)	120 (90.2)	49 (81.7)
Yes	21 (10.9)	11 (8.3)	10 (16.7)
Pregnant⁵, n (%)				0.085
No	51 (89.4)	39 (86.7)	12 (100)
Yes	6 (10.5)	6 (13.3)	0
Breast feeding, n (%)				0.110
No	54 (94.7)	43 (95.6)	11 (91.7)
Yes	3 (5.3)	2 (4.4)	1 (8.3)
Alcohol abuse, n (%)				0.172
No	158 (81.9)	105 (78.9)	53 (88.3)
Yes	35 (18.1)	28 (21.1)	7 (11.7)
Khat abuse, n (%)				0.001^a
No	88 (45.6)	71 (53.4)	17 (28.3)
Yes	105 (54.4)	62 (46.6)	43 (71.7)

^aP < 0.05.

¹A total of 6 missing values, of whom 1 had cirrhosis.

²A total of 40 missing values, of whom 9 had cirrhosis.

³Data missing in 1 patient without cirrhosis.

⁴A total of 3 missing values, of whom 1 had cirrhosis.

⁵A total of 2 missing values, of whom none had cirrhosis.

Table 3 Clinical presentation of patients with chronic hepatitis B, by cirrhosis status, Harar, Eastern Ethiopia

Variables	All patients, n = 193	No cirrhosis, n = 133	Cirrhosis, n = 60	P value
Symptoms, n (%)	69 (35.8)	58 (43.6)	57 (95.0)	< 0.001^a
Jaundice	34 (17.6)	14 (10.5)	20 (33.3)	0.001^a
Abdominal pain	69 (35.8)	38 (28.6)	31 (51.7)	0.003^a
Abdominal swelling	57 (29.5)	20 (15)	37 (61.7)	< 0.001^a
Edema	32 (16.6)	6 (4.5)	26 (43.3)	< 0.001^a
Nausea/vomiting	36 (18.7)	13 (9.8)	23 (38.3)	< 0.001^a
Hematemesis	24 (12.4)	8 (6.0)	16 (26.7)	< 0.001^a
Pruritus	18 (9.3)	10 (7.5)	8 (13.3)	0.199
Muscle/joint aches	44 (22.8)	21 (15.8)	23 (38.3)	0.001^a
Confusion	13 (6.7)	9 (6.8)	4 (6.7)	0.979
Weight loss	51 (26.4)	18 (13.5)	33 (55.0)	< 0.001^a
Signs, n (%)
BMI < 18.5 kg/m²	34 (17.6)	6 (4.5)	49 (81.7)	< 0.001^a
Edema	30 (15.5)	18 (13.5)	12 (20.0)	0.033^a
Jaundice	12 (6.2)	0 (0)	12 (20.0)	< 0.001^a
Pale conjunctiva	10 (5.2)	1 (0.8)	9 (15.0)	< 0.001^a
Palmar erythema	14 (7.3)	2 (1.5)	12 (20.0)	< 0.001^a
Gynecomastia	8 (4.1)	0 (0)	8 (13.3)	0.011^a
Ascites	29 (15.0)	0 (0)	29 (48.3)	< 0.001^a
Splenomegaly	34 (17.6)	1 (0.8)	33 (55.0)	< 0.001^a
Ultrasound findings¹, n (%)
Normal liver surface	64 (47.8)	62 (80.5)	2 (3.5)	0.022^a
Mild uneven liver surface	11 (8.2)	5 (6.5)	6 (10.5)	0.478
Nodular and irregular surface	49 (36.6)	0 (0)	49 (86.0)	< 0.001^a
Other	10 (7.5)	10 (13.0)	0 (0)	0.057

^aP < 0.05.

¹A total of 59 missing values, of whom 3 patients had clinical signs of cirrhosis. BMI: Body mass index.

Table 4 Baseline biochemical, serologic, and virological data of patients with chronic hepatitis B, by cirrhosis status, Harar, Eastern Ethiopia

Variables	All patients, n = 193	No cirrhosis, n = 133	Cirrhosis, n = 60	P value
WBC as 10⁶/L	5.9 (4.1-7.7)	6.5 (4.9-7.8)	4.2 (3.0-6.3)	<0.001^a
Hemoglobin in g/L	14.7 (12.4-16.6)	15.5 (13.8-16.9)	11.8 (10.0-15.2)	< 0.001^a
Platelet count as 10⁹/L¹				<0.001^a
Median (IQR)	218 (119-294)	253 (184-344)	118 (54-180.3)
< 150, n (%)	60 (32.1)	20 (15.7)	40 (66.7)
≥ 150, n (%)	127 (67.9)	107 (84.3)	20 (33.3)
ALT (U/L)²				0.033^a
Median (IQR)	36 (23-58)	35 (22-52)	45 (27-84)
< 40, n (%)	96 (52.5)	70 (55.6)	26 (45.6)
≥ 40, n (%)	87 (47.5)	56 (44.4)	31 (54.4)
AST as IU/L³				0.016^a
Median (IQR)	40 (29-65)	36 (28-57)	51 (34-81)
< 40, n (%)	90 (49.5)	67 (53.6)	23 (40.4)
≥ 40, n (%)	92 (50.5)	58 (46.4)	34 (59.6)
Creatinine in mg/dL⁴				0.750
Median (IQR)	0.8 (0.6-1.0)	0.8 (0.6-1.0)	0.8 (0.6-1.0)
≤ 1.2, n (%)	150 (90.4)	101 (91.0)	49 (89.1)
> 1.2, n (%)	16 (9.6)	10 (9.0)	6 (10.9)
APRI score⁵				< 0.001^a
Median (IQR)	0.52 (0.29-1.35)	0.38 (0.26-0.70)	1.53 (0.66-2.84)
< 1.5, n (%)	136 (77.7)	108 (91.5)	28 (49.1)
≥ 1.5, n (%)	39 (22.3)	10 (8.5)	29 (50.9)
FIB-4 score⁶				< 0.001^a
Median (IQR)	1.06 (0.60-1.98)	0.85 (0.55-1.41)	1.93 (1.03-4.08)
≤ 3.25, n (%)	142 (82.6)	106 (90.6)	36 (65.5)
> 3.25, n (%)	30 (17.4)	11 (9.4)	19 (34.5)
HBeAg⁷				0.001^a
Negative, n (%)	105 (78.9)	80 (87.9)	25 (59.5)
Positive, n (%)	28 (21.1)	11 (12.8)	17 (40.5)
HBV viral load in IU/mL⁸				< 0.001^a
Median (IQR)	677 (135-7580)	486 (105-2863)	2843 (313-805407)
< 2000, n (%)	114 (64.4)	91 (72.2)	23 (45.1)
2000-19999, n (%)	24 (13.6)	15 (11.9)	9 (17.6)
≥ 20000, n (%)	39 (22.0)	20 (15.9)	19 (37.3)

^aP < 0.05.

¹A total of 6 missing values, of whom none had cirrhosis.

²A total of 10 missing values, of whom 3 had cirrhosis.

³A total of 11 missing values, of whom 3 had cirrhosis.

⁴A total of 27 missing values, of whom 3 had cirrhosis.

⁵A total of 18 missing values, of whom 3 had cirrhosis.

⁶A total of 21 missing values, of whom 5 had cirrhosis.

⁷A total of 60 missing values, of whom 18 had cirrhosis.

⁸A total of 16 missing values, of whom 9 had cirrhosis. ALT: Alanine aminotransferase; APRI: Aspartate aminotransferase to platelet ratio index; AST: Aspartate aminotransferase; FIB-4: Fibrosis-4; HBeAg: Hepatitis B envelope antigen; HBV: Hepatitis B virus; IQR: Interquartile range; WBC: White blood cell count.

Table 5 Factors associated with cirrhosis among patients with chronic hepatitis B, Harar, Eastern Ethiopia

Baseline variables	No cirrhosis, n = 133	Cirrhosis, n = 60	Bivariable		Multivariable
Baseline variables	No cirrhosis, n = 133	Cirrhosis, n = 60	COR (95%CI)	P value	AOR (95%CI)	P value
Sex, n (%)				0.022		0.308
Female	49 (36.8)	12 (20.0)	1		1
Male	84 (63.2)	48 (80.0)	2.33 (1.13-4.81)		1.74 (0.72-4.20)
Age group by years, n (%)				0.635
< 40	100 (75.2)	47 (78.3)	1
≥ 40	33 (24.8)	13 (26.7)	0.84 (0.40-1.74)
Alcohol abuse, n (%)				0.122
No	105 (78.9)	53 (88.3)	1
Yes	28 (21.1)	7 (11.7)	0.49 (0.20-1.21)
Khat abuse, n (%)				0.002		0.003^a
No	71 (53.4)	17 (28.3)	1		1
Yes	62 (46.6)	43 (71.7)	2.89 (1.50-5.59)		2.86 (1.44-5.68)
ALT in U/L¹, n (%)				0.213
< 40	70 (55.6)	26 (45.6)	1
≥ 40	56 (44.4)	31 (54.4)	1.49 (0.79-2.79)
AST in U/L², n (%)				0.099
< 40	67 (53.6)	23 (40.4)	1
≥ 40	58 (46.4)	34 (59.6)	1.71 (0.91-3.22)
HBeAg³, n (%)				0.007		0.022^a
Negative	80 (87.9)	25 (59.5)	1		1
Positive	11 (12.8)	17 (40.5)	3.61 (1.41-9.21)		3.81 (1.21-11.98)
HBV viral load in IU/mL⁴, n (%)				0.001		0.004^a
< 2000	91 (79.8)	23 (45.1)	1		1
≥ 2000	35 (20.2)	28 (54.9)	3.17 (1.61-6.23)		5.29 (1.72-16.33)

^aP < 0.05.

¹A total of 10 missing values, of whom 3 had cirrhosis at baseline.

²A total of 11 missing values, of whom 3 had cirrhosis at baseline.

³A total of 61 missing values, of whom 18 had cirrhosis at baseline.

⁴A total of 16 missing values, of whom 9 had cirrhosis at baseline. ALT: Alanine aminotransferase; AOR: Adjusted odds ratio; AST: Aspartate aminotransferase; CI: Confidence interval; COR: Crudes odds ratio; HBeAg: Hepatitis B envelope antigen; HBV: Hepatitis B virus.

Citation: Ismael NY, Usmael SA, Belay NB, Mekonen HD, Johannessen A, Orlien SM. Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis. World J Hepatol 2024; 16(7): 995-1008
URL: https://www.wjgnet.com/1948-5182/full/v16/i7/995.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i7.995